We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£515.00
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India
Price data last checked 81 day(s) ago - refreshing...
Price History & Forecast
Last 10 days • 10 data points (No recent data available)
Price Distribution
Price distribution over 10 days • 1 price levels
Price Analysis
Most common price: £515 (10 days, 100.0%)
Price range: £515 - £515
Price levels: 1 different prices over 10 days
Product Specifications
- Format
- paperback
- ASIN
- B0BGKX2GGT
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 14 September 2022
- Listed Since
- 28 September 2022
Similar Products You Might Like
98% match
The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics
£795.00
11 Feb 2026
97% match
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
£515.00
22 Jan 2026
97% match
The 2023-2028 Outlook for Gonorrhea Therapeutics in India
£515.00
09 Feb 2026
97% match
The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in India
£515.00
12 Feb 2026
97% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
£515.00
22 Jan 2026
97% match
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
£515.00
11 Jan 2026
97% match
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India
£515.00
26 Jan 2026
96% match
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India
£515.00
06 Feb 2026
96% match
The 2023-2028 Outlook for Digital Therapeutics Sales in India
£515.00
26 Jan 2026
96% match
The 2023-2028 Outlook for Sarcopenia Treatments in India
£515.00
29 Jan 2026
96% match
The 2023-2028 Outlook for Insomnia Therapeutics in India
£515.00
25 Jan 2026
96% match
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in India
£515.00
25 Jan 2026
96% match
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in India
£515.00
23 Jan 2026
96% match
The 2023-2028 Outlook for Motion Sickness Treatments in India
£515.00
06 Feb 2026
96% match
The 2023-2028 Outlook for External Neurostimulation in India
£515.00
22 Jan 2026
96% match
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in India
£515.00
10 Dec 2025
96% match
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in India
£515.00
06 Feb 2026
96% match
The 2023-2028 Outlook for HIV and AIDS Therapeutics in India
£515.00
23 Jan 2026
96% match
The 2023-2028 Outlook for Myasthenia Gravis in India
£515.00
10 Feb 2026
96% match
The 2023-2028 Outlook for Anti-Malarial Drugs in India
£515.00
22 Jan 2026
96% match
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India
£515.00
22 Jan 2026
96% match
The 2023-2028 Outlook for Intravenous Therapy and Vein Access in India
£515.00
27 Jan 2026
96% match
The 2023-2028 Outlook for Antiviral Drugs in India
£515.00
29 Jan 2026
96% match
The 2023-2028 Outlook for Diabetic Neuropathy in India
£515.00
13 Jan 2026